FDA — authorised 23 August 2021
- Marketing authorisation holder: CARA THERAPEUTICS INC
- Status: approved
🇺🇸 Korsuva in United States
FDA authorised Korsuva on 23 August 2021
Marketing authorisations
FDA — authorised 23 August 2021
- Application: NDA214916
- Marketing authorisation holder: VIFOR INTL
- Local brand name: KORSUVA
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Korsuva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Korsuva approved in United States?
Yes. FDA authorised it on 23 August 2021; FDA authorised it on 23 August 2021.
Who is the marketing authorisation holder for Korsuva in United States?
CARA THERAPEUTICS INC holds the US marketing authorisation.